RPS6KB1 and metabolic dysfunction-associated steatotic liver disease: In an animal model with NAFLD, Wang (2018) found that lncRNA-NEAT1 knockdown may alleviate the NAFLD via regulating the mTOR/S6K1 signaling pathway.